An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the effect of simvastatin plus Omacor to
simvastatin plus placebo for lowering non-high density lipoprotein cholesterol in subjects
with mixed dyslipidemia.